Ogasawara, S., Itoh, S., Sugimoto, R., Kugiyama, Y., Hirai, F., Hayashi, H., Honma, Y., Mawatari, S., Shirabe, K., Koyanagi, T., Kuwashiro, T., Maeshiro, T., Hiraoka, A., Harimoto, N., Ichiki, Y., Koga, F., Fukuzawa, K., Tetsutaro, H., Oki, E., Yoshizumi, T. (2026). Real-world prospective comparison of sorafenib and lenvatinib as first-line therapy for unresectable hepatocellular carcinoma: A multicenter study in Japan (KSCC HAMRET).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.562